TP53 and hepatocellular carcinoma: Recently, p53 mRNA delivery by nanoparticles shows potential anticancer effect alone or in combination with immune checkpoint blockade in HCC mouse models.495,496 Targeting p53 is typically regarded as suppressing tumors through apoptosis and cell cycle arrest.